(Q35595393)

9 August 2017

1 reference

title

In vitro trans-monolayer permeability calculations: often forgotten assumptions (English)

1 reference

9 August 2017

Kuresh A Youdim

1

1 reference

9 August 2017

Alex Avdeef

series ordinal

2

1 reference

9 August 2017

N Joan Abbott

series ordinal

3

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

issue

21

1 reference

9 August 2017

page(s)

997-1003

1 reference

Human intestinal permeability

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Experimental and computational screening models for the prediction of intestinal drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

In vitro models of the blood-brain barrier to polar permeants: comparison of transmonolayer flux measurements and cell uptake kinetics using cultured cerebral capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Physicochemical profiling (solubility, permeability and charge state).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Interaction between flavonoids and the blood-brain barrier: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

High throughput artificial membrane permeability assay for blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Lipids in blood-brain barrier models in vitro I: Thin-layer chromatography and high-performance liquid chromatography for the analysis of lipid classes and long-chain polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Diffusion of Weak Acids across Lipid Bilayer Membranes: Effects of Chemical Reactions in the Unstirred Layers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Diffusion of carbon dioxide through lipid bilayer membranes: effects of carbonic anhydrase, bicarbonate, and unstirred layers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Monocarboxylic acid permeation through lipid bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902873-3

7 January 2021

10.1016/S1359-6446(03)02873-3

Identifiers

DOI

1 reference

9 August 2017

1 reference